Heparin Sodium Market Report 2019 - 2026, Growth Trend, Revenue, Sales Volume Estimation and Forecast

By Type (Heparinoids, low molecular weight heparin and Unfractioned heparin), By Application (complications of pregnancy, venous thromboembolism, cardio version of atrial flutter and others), By Region(North America, Europe, APAC and Rest of the World)

LATEST: This report includes COVID 19 Impact Analysis of the Market

  • Report ID : MD1223
  • |
  • Pages : 185
  • |
  • Tables : 95
  • |
  • Formats :

Heparin Sodium market revenue is estimated to be $XX Billion in 2018 and shall grow with a CAGR of XX.X% during the forecast period of 2019 to 2026.

Due to the wide demand of heparin sodium in the medical field, this market is expected to grow rapidly in the coming years. Heparin sodium helps in preventing blood clot formation and thus is widely used in the medical field to increase the growth of the heparin sodium market. The high availability of raw materials used for the manufacture of heparin sodium is an important factor responsible for the development of the market's revenues. Major raw materials are preservatives, pancreatic enzymes, ion exchange resin, and fresh intestines. However, fluctuation in the raw materials of heparin sodium is a hindrance to the development of the industry. Besides, the sales in the market are expected to increase the cost of production of heparin sodium by the cheapest cost. The increasing consumption of cardio variants of various functions of the medical sector such as pregnancy complications, venous thromboembolism, and atrial flutter are responsible for the increase in heparin sodium market shares.

Due to the growing problem of thrombosis in consumers, the government is enforcing strict rules and regulations to implement advanced treatment techniques in hospitals. However, there is a lack of awareness among the patient population about the availability of such advanced treatment. This can be a major hurdle for the heparin sodium market growth during the forecast period. However, in emerging economies, the key players in need of no medical needs are attracted to investing in the methods of health care treatment. It is anticipated to provide attractive growth opportunities for the global heparin sodium market.

The rapid development of the medical infrastructure across the world is likely to fuel up the heparin sodium market sales during the forecast period:

The Asia Pacific region has shown tremendous growth in its market sales and is estimated to dominate the overall revenue over the forecast period owing to the rising use of the gadgets such as smartphones and tablets in the developing countries such as India, China, and Japan in the region. Further, the North American region has registered for significant market growth followed by the Europe region. Rising standards of medical infrastructure and stringency in the rules implemented by the government are responsible for a significant increase in the heparin sodium market sales. Moreover, the Middle-East and South Africa are expected to support the market growth substantially over the forecast period.
 
Cost-effectiveness of heparin sodium is expected to lead the heparin sodium market revenue:

This market can be segmented into type, application, and region. In terms of type, the segmentation has been done as heparinoids, low molecular weight heparin, and Unfractioned heparin. By application, the segmentation has been done as complications of pregnancy, venous thromboembolism, cardioversion of atrial flutter and others. Moreover, the cost of heparin sodium plays a vital role in setting up the heparin sodium market trend.

Heparin sodium manufacturers:

Major industry players have been analyzed with coverage on their operating areas, revenues, and other strategic aspects. Various industry players are adopting advanced strategies to gain maximum profit. These industry players include Shenzhen Hepalink, Sichuan Deebio Pharmaceutical Co.LTD., Hebei Changshan, Biochemical Pharmaceutical Co., Ltd., Nanjing Xinbai Pharmaceutical Co., Ltd., Yantai Dongcheng Biochemicals Co. Ltd., Bioibrica, Aspen Oss BV, Pharma Action GmbH, Opocrin S.p.A and Pfizer Incorporated.

Key Points covered in the Report:
        
•    Revenue Estimation and Forecast (2018 – 2026)
•    Production Estimation and Forecast (2018 – 2026)
•    Sales/Consumption Volume Estimation and Forecast (2018 – 2026)
•    Breakdown of Revenue by Segments (2018 – 2026)
•    Breakdown of Production by Segments (2018 – 2026)
•    Breakdown of Sales Volume by Segments (2018 – 2026)
•    Gross Margin and Profitability Analysis of Companies
•    Business Trend and Expansion Analysis
•    Import and Export Analysis
•    Regional Analysis and Data Breakdown

MARKET SEGMENTATION

By TypeOutlook ($Revenue and Unit Sales, 2018-2026)

•    Heparinoids
•    Low molecular weight heparin
•    Unfractionated heparin

By Application Outlook ($Revenue and Unit Sales, 2018-2026)
 
•    Complications of pregnancy
•    Venous thromboembolism
•    The cardio version of atrial flutter
•    Others

By Regional Outlook ($Revenue and Unit Sales, 2018-2026)

•    North America
•    Canada
•    U.S
•    Mexico
•    Europe
•    Germany
•    France
•    U.K
•    Rest of Europe 

•    Asia-Pacific
•    China
•    India
•    Japan
•    Rest of Asia Pacific
•    Rest of the World
•    Middle East
•    Africa
•    Latin America

Heparin sodium manufacturers:

•    Shenzhen Hepalink
•    Sichuan Deebio Pharmaceutical Co.LTD.
•    Hebei Changshan
•    Biochemical Pharmaceutical Co., Ltd.
•    Nanjing Xinbai Pharmaceutical Co., Ltd.
•    Yantai Dongcheng Biochemicals Co. Ltd.
•    Bioibrica
•    Aspen Oss BV
•    Pharma Action GmbH
•    Opocrin S.p.A
•    Pfizer Incorporated

 

CHAPTER 1:  INTRODUCTION

1.1. Research Methodology

1.1.1. Desk Research

1.1.2. Data Synthesis

1.1.3. Data Validation & Market Feedback

1.1.4. Data Sources

CHAPTER 2:  EXECUTIVE SUMMARY

2.1. Global Market Outlook

2.2. Core Insights - Type

2.3. Core Insights – Application

2.4. Core Insights – Geography

CHAPTER 3:  MARKET OVERVIEW

3.1.  Market Definition and Scope

3.2. Key Forces Shaping the Industry

3.2.1. Bargaining Power of Suppliers

3.2.2. Bargaining Power of Buyers

3.2.3. Threat of Substitutes

3.2.4. Threat of New Entrants

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Supply-side Drivers

3.3.1.2. Demand-side Drivers

3.3.2. Restraints

3.3.3. Opportunities

3.4. Industry Landscape - PESTEL Analysis

3.4.1. Political Landscape

3.4.2. Environmental Landscape

3.4.3. Social Landscape

3.4.4. Technology Landscape

3.4.5. Economic Landscape

CHAPTER 4:  MARKET BACKGROUND

4.1. Industry Value Chain Analysis

4.1.1. Upstream Participants

4.1.2. Downstream participants

4.2. Pricing Analysis and Forecast, 2018-2026

4.2.1. By Type

4.2.2. By Region

CHAPTER 5:  GLOBAL HEPARIN SODIUM MARKET, BY TYPE

5.1. Overview

5.1.1. Market Volume and Forecast, 2018-2026

5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

5.2. Heparinoids

5.2.1. Key Market Trends, Growth Factors and Opportunities

5.2.2. Market Volume and Forecast, By Region

5.2.3. Market Revenue (US$ Million) and Forecast, By Region

5.3. Low molecular weight heparin

5.3.1. Key Market Trends, Growth Factors and Opportunities

5.3.2. Market Volume and Forecast, By Region

5.3.3. Market Revenue (US$ Million) and Forecast, By Region

5.4. Unfractionated heparin

5.4.1. Key Market Trends, Growth Factors and Opportunities

5.4.2. Market Volume and Forecast, By Region

5.4.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 6:  GLOBAL HEPARIN SODIUM MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market Volume and Forecast, 2018-2026

6.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

6.2. Complications of pregnancy

6.2.1. Key Market Trends, Growth Factors and Opportunities

6.2.2. Market Volume and Forecast, By Region

6.2.3. Market Revenue (US$ Million) and Forecast, By Region

6.3. Venous thromboembolism

6.3.1. Key Market Trends, Growth Factors and Opportunities

6.3.2. Market Volume and Forecast, By Region

6.3.3. Market Revenue (US$ Million) and Forecast, By Region

6.4. The cardio version of atrial flutter

6.4.1. Key Market Trends, Growth Factors and Opportunities

6.4.2. Market Volume and Forecast, By Region

6.4.3. Market Revenue (US$ Million) and Forecast, By Region

6.5. Others

6.5.1. Key Market Trends, Growth Factors and Opportunities

6.5.2. Market Volume and Forecast, By Region

6.5.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 7:  GLOBAL HEPARIN SODIUM MARKET, BY GEOGRAPHY

7.1. Overview

7.2. North America

7.2.1. Key Market Trends, Growth Factors and Opportunities

7.2.2. Market Volume and Forecast, By Type

7.2.3. Market Volume and Forecast, By Application

7.2.4. Market Revenue and Forecast, By Type

7.2.5. Market Revenue and Forecast, By Application

7.2.6. Market Revenue and Forecast, By Country

7.2.7. U.S.

7.2.7.1. Market Volume and Forecast

7.2.7.2. Market Revenue and Forecast

7.2.8. Canada

7.2.8.1. Market Volume and Forecast

7.2.8.2. Market Revenue and Forecast

7.2.9. Mexico

7.2.9.1. Market Volume and Forecast

7.2.9.2. Market Revenue and Forecast

7.3. Europe

7.3.1. Market Volume and Forecast, By Type

7.3.2. Market Volume and Forecast, By Application

7.3.3. Market Revenue and Forecast, By Type

7.3.4. Market Revenue and Forecast, By Application

7.3.5. Market Revenue and Forecast, By Country

7.3.6. Germany

7.3.6.1. Market Volume and Forecast, By Type

7.3.6.2. Market Revenue and Forecast, By Application

7.3.7. UK

7.3.7.1. Market Volume and Forecast, By Type

7.3.7.2. Market Revenue and Forecast, By Application

7.3.8. France

7.3.8.1. Market Volume and Forecast, By Type

7.3.8.2. Market Revenue and Forecast, By Application

7.3.9. Italy

7.3.9.1. Market Volume and Forecast, By Type

7.3.9.2. Market Revenue and Forecast, By Application

7.3.10. Rest of Europe

7.3.10.1. Market Volume and Forecast, By Type

7.3.10.2. Market Revenue and Forecast, By Application

7.4. Asia-Pacific

7.4.1. Market Volume and Forecast, By Type

7.4.2. Market Volume and Forecast, By Application

7.4.3. Market Revenue and Forecast, By Type

7.4.4. Market Revenue and Forecast, By Application

7.4.5. Market Revenue and Forecast, By Country

7.4.6. China

7.4.6.1. Market Volume and Forecast, By Type

7.4.6.2. Market Revenue and Forecast, By Application

7.4.7. India

7.4.7.1. Market Volume and Forecast, By Type

7.4.7.2. Market Revenue and Forecast, By Application

7.4.8. Japan

7.4.8.1. Market Volume and Forecast, By Type

7.4.8.2. Market Revenue and Forecast, By Application

7.4.9. South Korea

7.4.9.1. Market Volume and Forecast, By Type

7.4.9.2. Market Revenue and Forecast, By Application

7.4.10. Rest of Asia-Pacific

7.4.10.1. Market Volume and Forecast, By Type

7.4.10.2. Market Revenue and Forecast, By Application

7.5. REST OF THE WORLD

7.5.1. Market Volume and Forecast, By Type

7.5.2. Market Volume and Forecast, By Application

7.5.3. Market Revenue and Forecast, By Type

7.5.4. Market Revenue and Forecast, By Application

7.5.5. Market Revenue and Forecast, By Country

7.5.6. Latin America

7.5.6.1. Market Volume and Forecast, By Type

7.5.6.2. Market Revenue and Forecast, By Application

7.5.7. Middle East

7.5.7.1. Market Volume and Forecast, By Type

7.5.7.2. Market Revenue and Forecast, By Application

7.5.8. Africa

7.5.8.1. Market Volume and Forecast, By Type

7.5.8.2. Market Revenue and Forecast, By Application

CHAPTER 8:  COMPETITIVE LANDSCAPE

8.1. Heparin Sodium Market Share Analysis, 2018

CHAPTER 9:  COMPANY PROFILES

9.1. Shenzhen Hepalink

9.1.1. Company Overview

9.1.2. Financial Performance

9.1.3. SWOT Analysis

9.2. Sichuan Deebio Pharmaceutical Co.LTD.

9.2.1. Company Overview

9.2.2. Financial Performance

9.2.3. SWOT Analysis

9.3. Hebei Changshan

9.3.1. Company Overview

9.3.2. Financial Performance

9.3.3. SWOT Analysis

9.4. Biochemical Pharmaceutical Co., Ltd.

9.4.1. Company Overview

9.4.2. Financial Performance

9.4.3. SWOT Analysis

9.5. Nanjing Xinbai Pharmaceutical Co., Ltd.

9.5.1. Company Overview

9.5.2. Financial Performance

9.5.3. SWOT Analysis

9.6. Yantai Dongcheng Biochemicals Co. Ltd.

9.6.1. Company Overview

9.6.2. Financial Performance

9.6.3. SWOT Analysis

9.7. Bioibrica

9.7.1. Company Overview

9.7.2. Financial Performance

9.7.3. SWOT Analysis

9.8. Aspen Oss BV

9.8.1. Company Overview

9.8.2. Financial Performance

9.8.3. SWOT Analysis

9.9. Pharma Action GmbH

9.9.1. Company Overview

9.9.2. Financial Performance

9.9.3. SWOT Analysis

9.10. Opocrin S.p.A

9.10.1. Company Overview

9.10.2. Financial Performance

9.10.3. SWOT Analysis

9.11. Pfizer Incorporated

9.11.1. Company Overview

9.11.2. Financial Performance

9.11.3. SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com